{"id":"https://openalex.org/W2594870710","doi":"https://doi.org/10.1182/blood.v126.23.189.189","title":"Quadruplet Vs Sequential Triplet Induction Therapy Approaches to Maximise Response for Newly Diagnosed, Transplant Eligible, Myeloma Patients","display_name":"Quadruplet Vs Sequential Triplet Induction Therapy Approaches to Maximise Response for Newly Diagnosed, Transplant Eligible, Myeloma Patients","alternate_titles":[],"publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2594870710","doi":"https://doi.org/10.1182/blood.v126.23.189.189","mag":"2594870710"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.189.189","doi":"https://doi.org/10.1182/blood.v126.23.189.189","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.189.189","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2594870710"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.25405/ncl.34273842","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072977279","display_name":"Charlotte Pawlyn","orcid":"https://orcid.org/0000-0002-7190-0028","observed_orcids":["https://orcid.org/0000-0002-7190-0028"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Pawlyn","raw_affiliation_strings":["Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034560778","display_name":"Faith E. Davies","orcid":"https://orcid.org/0000-0002-3971-2393","observed_orcids":["https://orcid.org/0000-0002-3971-2393"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Faith E Davies","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042419236","display_name":"David Allan Cairns","orcid":"https://orcid.org/0000-0002-2338-0179","observed_orcids":["https://orcid.org/0000-0002-2338-0179"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David A Cairns","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027410624","display_name":"Corinne Collett","orcid":"https://orcid.org/0000-0002-5510-1488","observed_orcids":["https://orcid.org/0000-0002-5510-1488"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Corinne Collett","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103137464","display_name":"Anna Weinberg Chalmers","orcid":"https://orcid.org/0000-0003-4832-0022","observed_orcids":["https://orcid.org/0000-0003-4832-0022"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Chalmers","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070244650","display_name":"Alina Striha","orcid":"https://orcid.org/0000-0003-3363-8417","observed_orcids":["https://orcid.org/0000-0003-3363-8417"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alina Striha","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058317897","display_name":"John R Jones","orcid":"https://orcid.org/0000-0002-1401-6105","observed_orcids":["https://orcid.org/0000-0002-1401-6105"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John R Jones","raw_affiliation_strings":["Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033344593","display_name":"Mamta Krishnan Garg","orcid":"https://orcid.org/0000-0002-3560-0132","observed_orcids":["https://orcid.org/0000-0002-3560-0132"]},"institutions":[{"id":"https://openalex.org/I2800281165","display_name":"Leicester Royal Infirmary","ror":"https://ror.org/03jkz2y73","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800281165","https://openalex.org/I2802445252"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mamta Garg","raw_affiliation_strings":["Leicester Royal Infirmary, Leicester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leicester Royal Infirmary, Leicester, United Kingdom","institution_ids":["https://openalex.org/I2800281165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020282881","display_name":"David Allotey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799342194","display_name":"Royal Derby Hospital","ror":"https://ror.org/005r9p256","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799342194","https://openalex.org/I4210149821"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Allotey","raw_affiliation_strings":["Royal Derby Hospital, Derby, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Derby Hospital, Derby, United Kingdom","institution_ids":["https://openalex.org/I2799342194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008572050","display_name":"Kamaraj Karunanithi","orcid":"https://orcid.org/0000-0002-4708-8092","observed_orcids":["https://orcid.org/0000-0002-4708-8092"]},"institutions":[{"id":"https://openalex.org/I2800115762","display_name":"University Hospitals of North Midlands NHS Trust","ror":"https://ror.org/03g47g866","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800115762"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kamaraj Karunanithi","raw_affiliation_strings":["University Hospital of North Midlands, Stoke-on-Trent, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of North Midlands, Stoke-on-Trent, United Kingdom","institution_ids":["https://openalex.org/I2800115762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110052900","display_name":"Donald William Milligan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799726393","display_name":"Heart of England NHS Foundation Trust","ror":"https://ror.org/041rme308","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799726393"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Donald Milligan","raw_affiliation_strings":["Heart of England NHS Foundation Trust, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heart of England NHS Foundation Trust, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I2799726393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073477610","display_name":"Martin Kaiser","orcid":"https://orcid.org/0000-0002-3677-4804","observed_orcids":["https://orcid.org/0000-0002-3677-4804"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin F Kaiser","raw_affiliation_strings":["Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083949340","display_name":"Matthew W. Jenner","orcid":"https://orcid.org/0000-0003-0216-7464","observed_orcids":["https://orcid.org/0000-0003-0216-7464"]},"institutions":[{"id":"https://openalex.org/I2801388914","display_name":"Southampton General Hospital","ror":"https://ror.org/011cztj49","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801388914","https://openalex.org/I2802965805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew W Jenner","raw_affiliation_strings":["Southampton General Hospital, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southampton General Hospital, Southampton, United Kingdom","institution_ids":["https://openalex.org/I2801388914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038580329","display_name":"Gordon Cook","orcid":"https://orcid.org/0000-0003-1717-0412","observed_orcids":["https://orcid.org/0000-0003-1717-0412"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gordon Cook","raw_affiliation_strings":["University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035489508","display_name":"Nigel H. Russell","orcid":"https://orcid.org/0000-0003-1893-8155","observed_orcids":["https://orcid.org/0000-0003-1893-8155"]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nigel H. Russell","raw_affiliation_strings":["Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053100242","display_name":"Mark Trehane Drayson","orcid":"https://orcid.org/0000-0002-1528-7564","observed_orcids":["https://orcid.org/0000-0002-1528-7564"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark T Drayson","raw_affiliation_strings":["Clinical Immunology, School of Immunity & Infection, University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, School of Immunity & Infection, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063301766","display_name":"Roger G. Owen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roger G Owen","raw_affiliation_strings":["St. James's University Hospital, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. James's University Hospital, Leeds, United Kingdom","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017165070","display_name":"Walter Martin Gregory","orcid":"https://orcid.org/0000-0003-2641-8416","observed_orcids":["https://orcid.org/0000-0003-2641-8416"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Walter M Gregory","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081247376","display_name":"Graham Hunter Jackson","orcid":"https://orcid.org/0000-0003-0756-969X","observed_orcids":["https://orcid.org/0000-0003-0756-969X"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham H Jackson","raw_affiliation_strings":["Department of Haematology, University of Newcastle, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, University of Newcastle, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100632493","display_name":"Gareth John Morgan","orcid":"https://orcid.org/0000-0002-4271-6360","observed_orcids":["https://orcid.org/0000-0002-4271-6360","https://orcid.org/0000-0002-1275-2010","https://orcid.org/0000-0001-7073-2723"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Gareth J Morgan","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2207,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.5389733,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"126","issue":"23","first_page":"189","last_page":"189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8629999756813049},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.8849999904632568},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9729999899864197},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.8539999723434448},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8759999871253967},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9210000038146973},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.8730000257492065},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7620000243186951},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.9169999957084656},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9380000233650208}],"concepts":[{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.8391069173812866},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8169904351234436},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7042369842529297},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.678358793258667},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.6675238609313965},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.6554926037788391},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5781756043434143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5077623128890991},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4754982888698578},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.4656553864479065},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3750821650028229},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2694680690765381}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v126.23.189.189","doi":"https://doi.org/10.1182/blood.v126.23.189.189","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.189.189","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.25405/ncl.34273842","doi":"https://doi.org/10.25405/ncl.34273842","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34273842","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ConferenceProceeding"},{"id":"doi:10.25405/ncl.34273842.v1","doi":"https://doi.org/10.25405/ncl.34273842.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34273842.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ConferenceProceeding"}],"best_oa_location":{"id":"doi:10.25405/ncl.34273842","doi":"https://doi.org/10.25405/ncl.34273842","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34273842","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ConferenceProceeding"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2508889976","https://openalex.org/W2900309611","https://openalex.org/W2202273096","https://openalex.org/W2980570729","https://openalex.org/W2980593184","https://openalex.org/W7204703481","https://openalex.org/W4399480663","https://openalex.org/W4417005305","https://openalex.org/W4402371458","https://openalex.org/W2590770955"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Maximising":[2],"response":[3,139,221,261,294,304,337,356,507,521,548,603],"in":[4,103,362,436,465,479,494,585],"myeloma":[5,719],"(MM)":[6],"patients":[7,107,223,274,289,314,329,346,404,411,439,466,541,555],"with":[8,69,136,224,290,308,366,370,606],"effective":[9,61],"induction":[10,409,476,528,716],"regimens":[11,25,57,609],"prior":[12,141,262,279,332,382],"to":[13,76,99,116,142,152,179,219,228,233,259,263,280,297,319,333,353,360,378,383,392,395,407,443,446,451,457,486,489,549,590,600],"autologous":[14],"stem":[15],"cell":[16],"transplant":[17,104],"(ASCT)":[18],"improves":[19],"progression-free":[20],"and":[21,62,114,249,306,426,453,500,505,564,580,610,721],"overall":[22,375],"survival.":[23],"Triplet":[24],"combining":[26,576],"an":[27,52,400,537,571,832,848,860],"immunomodulatory":[28],"agent":[29],"(IMiD)":[30],"and/or":[31],"proteasome":[32],"inhibitor":[33],"(PI)":[34],"are":[35,177,231,257,477],"standard":[36],"of":[37,83,120,187,364,399,438,474,526,615,632,707,729,835,851,863,878],"care,":[38],"however":[39],"a":[40,93,137,269,291,354,416,520],"more":[41,60],"personalised":[42],"approach":[43,381,398,552],"is":[44,92,268,583],"achieved":[45,605],"by":[46,129],"sequential":[47,118,185,234,253,349,558],"triplet":[48,121,132,350],"combinations":[49,123],"based":[50],"on":[51,296,496,509,831,847,859],"individual's":[53],"response.":[54],"Alternatively,":[55],"quadruplet":[56,110,182],"may":[58],"be":[59,386,393,487,512,562,595],"new":[63],"generation":[64,578],"PIs":[65],"such":[66],"as":[67,715,723],"carfilzomib,":[68,111,444],"less":[70],"off-target":[71],"activity,":[72],"provide":[73],"the":[74,81,109,117,147,184,276,334,348,374,396,410,515,524,550,598,602,607,616],"opportunity":[75],"investigate":[77],"this":[78,180,357,379],"whilst":[79],"minimising":[80],"risk":[82],"increased":[84],"toxicity.":[85],"The":[86,705],"UK":[87],"NCRI":[88,617],"Myeloma":[89],"XI":[90],"trial":[91,490],"large,":[94],"phase":[95],"III":[96],"study":[97,461,569],"aiming":[98],"answer":[100],"these":[101],"questions":[102],"eligible":[105],"(TE)":[106],"comparing":[108],"cyclophosphamide,":[112],"lenalidomide":[113,166],"dexamethasone":[115,171],"strategy":[119,186],"IMiD":[122,579],"(with":[124,553],"thalidomide":[125,210],"or":[126,183,204,247,837,853,865],"lenalidomide)":[127,447,452],"followed":[128],"additional":[130],"PI":[131,581],"therapy":[133],"for":[134,460,536,718,726,731,880],"those":[135,365],"suboptimal":[138,292,355],"(<VGPR)":[140],"ASCT.":[143],"Methods:":[144],"In":[145,567],"2013,":[146],"TE":[148,277,328,586],"pathway":[149,278],"was":[150,358],"amended":[151],"include":[153,519],"KCRD:":[154],"carfilzomib":[155],"36mg/m2":[156],"IV":[157],"d1-2,8-9,15-16":[158],"(20mg/m2":[159],"#1d1-2),":[160],"cyclophosphamide":[161],"(cyclo)":[162],"500mg":[163,190,207,237],"PO":[164,169,174,191,195,197,201,208,212,216,245],"d1,8,":[165,192],"(len)":[167],"25mg":[168,194],"d1-21,":[170],"(dex)":[172],"40mg":[173,200,215],"d1-4,8-9,15-16).":[175],"Patients":[176],"randomised":[178,232,317,406],"up-front":[181],"CRD:":[188],"cyclo":[189,206,236],"len":[193],"d1-21":[196],"daily,":[198,213],"dex":[199,214,243],"d1-4,":[202],"12-15":[203],"CTD:":[205],"d1,8,15":[209],"100-200mg":[211],"d1-4,12-15":[217],"given":[218,258],"max.":[220,260],"-":[222,696,697],"VGPR/CR":[225],"proceed":[226],"straight":[227],"ASCT,":[229,264],"PR/MR":[230],"CVD:":[235],"d1,8,15,":[238],"bortezomib":[239],"1.3mg/m2":[240],"IV/SC":[241],"d1,4,8,11,":[242],"20mg":[244],"d1,2,4,5,8,9,11,12":[246],"nothing":[248],"SD/PD":[250],"all":[251,655],"receive":[252,298],"CVD.":[254],"All":[255],"treatments":[256,725],"after":[265],"which":[266],"there":[267],"maintenance":[270,724],"randomisation.":[271],"Patients:":[272],"1512":[273],"entered":[275],"amendment":[281,335],"(756":[282],"CRD,":[283,324],"756":[284],"CTD).":[285,326],"Of":[286],"these,":[287],"201":[288],"initial":[293,367,408,475,527],"went":[295],"CVD,":[299],"142":[300],"following":[301],"randomisation":[302],"(initial":[303],"PR/MR)":[305],"59":[307],"NC/PD.":[309,371],"788":[310],"(of":[311],"target":[312],"n=1036)":[313],"have":[315,414,433,468,492,544],"been":[316,434],"post-amendment":[318],"date":[320],"(394":[321],"KCRD,":[322,497,570],"197":[323,325],"Results:":[327],"receiving":[330,347,412,440],"treatment":[331,380,611,717],"had":[336],"rates":[338,604],"\u2265VGPR:":[339],"CRD":[340,422,449,499,533,626],"58%":[341],"vs":[342,532,534],"CTD":[343,427,455,535,628],"52%.":[344],"For":[345],"CVD":[351],"due":[352,488],"upgraded":[359],"\u2265VGPR":[361,376],"49%":[363],"MR/PR,":[368],"27%":[369],"This":[372,389,517],"suggests":[373],"rate":[377],"ASCT":[384],"would":[385],"approx.":[387],"75%.":[388],"now":[390],"needs":[391],"compared":[394],"alternative":[397],"upfront":[401],"quadruplet.":[402],"Comparing":[403],"contemporaneously":[405],"KCRD":[413,441,531,624],"completed":[415,469,545],"median":[417],"4":[418],"cycles":[419],"(range":[420,424,429],"1-7),":[421],"5":[423],"1-10)":[425],"6":[428],"1-9).":[430],"Dose":[431],"modifications":[432],"required":[435],"62%":[437],"(56%":[442],"42%":[445],"44%":[448],"(40%":[450],"65%":[454],"(59%":[456],"thalidomide).":[458],"Data":[459,593],"drug":[462],"related":[463],"toxicity":[464,504],"who":[467,542],"at":[470,514,523,597],"least":[471],"one":[472],"cycle":[473],"shown":[478],"table":[480],"1.":[481,621],"Serious":[482],"adverse":[483],"events":[484],"suspected":[485],"medications":[491],"occurred":[493],"37%":[495],"32%":[498],"35%":[501],"CTD.":[502],"Updated":[503,547],"preliminary":[506],"analysis":[508],"23/09/15":[510],"will":[511,518,543,560,594],"presented":[513,563,596],"meeting.":[516],"comparison":[522],"end":[525],"regimen":[529,575],"i.e.":[530],"anticipated":[538],"700":[539],"contemporaneous":[540],"treatment.":[546],"sequencing":[551],"250":[554],"having":[556],"received":[557],"CVD)":[559],"also":[561],"compared.":[565],"Conclusions:":[566],"our":[568],"outpatient":[572],"delivered":[573],"4-drug":[574],"second":[577],"drugs,":[582],"well-tolerated":[584],"NDMM":[587],"patients,":[588],"comparable":[589],"3-drug":[591],"regimens.":[592],"meeting":[599],"compare":[601],"different":[608],"approaches.":[612],"On":[613],"behalf":[614],"Haemato-oncology":[618],"CSG":[619],"Table":[620],"Comparative":[622],"toxicities":[623],"n=261":[625],"n=143":[627],"n=142":[629],"%":[630],"(no.":[631],"patients)":[633],"Peripheral":[634],"neuropathy":[635],"Sensory":[636],"Gr":[637,646,664,673,682,692],"II-IV":[638,647],"1.9":[639],"(5)":[640],"1.4":[641,686,688],"(2)":[642,687,689],"8.5":[643],"(12)":[644],"Motor":[645],"3.1":[648],"(8)":[649,653,662,671],"1":[650],"(1)":[651,695],"5.6":[652,661,670],"VTE":[654],"grades":[656],"4.2":[657,668],"(11)":[658],"4.9":[659],"(7)":[660],"Anaemia":[663],"III-IV":[665,674,683,693],"9.2":[666],"(24)":[667],"(6)":[669],"Neutropenia":[672],"14.9":[675],"(39)":[676],"16.1":[677],"(22)":[678,685],"13.3":[679],"(19)":[680],"Thrombocytopenia":[681],"8.4":[684],"Infusion":[690],"reaction":[691],"0.4":[694],"Disclosures":[698],"Pawlyn:":[699],"Celgene:":[700,735,756,802,820],"Honoraria,":[701,758,768,773,778,783,788,793,799,804,813,829,845,857],"Other:":[702,742,810],"Travel":[703,743],"support;":[704],"Institute":[706],"Cancer":[708],"Research:":[709],"Employment.":[710],"Off":[711],"Label":[712],"Use:":[713],"Carfilzomib":[714],"Lenalidomide":[720],"vorinostat":[722],"myeloma.":[727],"Davies:University":[728],"Arkansas":[730,879],"Medical":[732,881],"Sciences:":[733,882],"Employment;":[734,883],"Honoraria;":[736,738,748,753,762,819,823,825,869,872,874,876,886],"Onyx-Amgen:":[737],"Takeda-Milenium:":[739],"Honoraria.":[740,764,817,821,827,888],"Jones:Celgene:":[741],"support,":[744],"Research":[745,759,805,814,840],"Funding.":[746,760],"Kaiser:Janssen:":[747],"Chugai:":[749,786],"Consultancy;":[750,755],"Amgen:":[751,763,781,824],"Consultancy,":[752,757,767,772,777,782,787,792,798,803],"BristolMyerSquibb:":[754],"Jenner:Takeda:":[761],"Cook:Jazz":[765],"Pharma:":[766],"Speakers":[769,774,779,784,789,794,800,807],"Bureau;":[770,775,780,785,790,795,801],"Sanofi:":[771],"Takeda:":[776,826],"Janssen:":[791,816],"Bristol-Myers":[796],"Squibb:":[797,844],"Funding,":[806],"Bureau.":[808],"Russell:Therakos:":[809],"shares.":[811],"Owen:Celgene:":[812],"Funding;":[815,841],"Gregory:Janssen:":[818],"Jackson:Celgene:":[822],"Morgan:Celgene:":[828],"Membership":[830,846,858],"entity's":[833,849,861],"Board":[834,850,862],"Directors":[836,852,864],"advisory":[838,854,866],"committees,":[839],"Bristol":[842],"Myers":[843],"committees;":[855,867],"Takeda-Millennium:":[856],"CancerNet:":[868,887],"Weisman":[870,884],"Institute:":[871,885],"MMRF:":[873,875],"University":[877]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2594870710","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2017-03-16T00:00:00"}
